# A Study to Assess Immune Response Status in Patients Before and After Treatment for Visceral Leishmaniasis

> **NCT04342715** · — · ACTIVE_NOT_RECRUITING · sponsor: **University of York** · enrollment: 216 (actual)

## Conditions studied

- Visceral Leishmaniasis

## Interventions

- **DRUG:** Sodium stibogluconate / paramomycin

## Key facts

- **NCT ID:** NCT04342715
- **Lead sponsor:** University of York
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-05-22
- **Primary completion:** 2025-05-31
- **Final completion:** 2026-03-31
- **Target enrollment:** 216 (ACTUAL)
- **Last updated:** 2025-07-24

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04342715

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04342715, "A Study to Assess Immune Response Status in Patients Before and After Treatment for Visceral Leishmaniasis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04342715. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*